JP2012506237A5 - - Google Patents

Download PDF

Info

Publication number
JP2012506237A5
JP2012506237A5 JP2011531514A JP2011531514A JP2012506237A5 JP 2012506237 A5 JP2012506237 A5 JP 2012506237A5 JP 2011531514 A JP2011531514 A JP 2011531514A JP 2011531514 A JP2011531514 A JP 2011531514A JP 2012506237 A5 JP2012506237 A5 JP 2012506237A5
Authority
JP
Japan
Prior art keywords
lip1
seq
sequence number
sign
variable domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011531514A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012506237A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/063655 external-priority patent/WO2010046337A2/en
Publication of JP2012506237A publication Critical patent/JP2012506237A/ja
Publication of JP2012506237A5 publication Critical patent/JP2012506237A5/ja
Pending legal-status Critical Current

Links

JP2011531514A 2008-10-21 2009-10-19 Dc−signに対する結合特異性をもつリガンド Pending JP2012506237A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10708508P 2008-10-21 2008-10-21
US61/107,085 2008-10-21
PCT/EP2009/063655 WO2010046337A2 (en) 2008-10-21 2009-10-19 Ligands that have binding specificity for dc-sign

Publications (2)

Publication Number Publication Date
JP2012506237A JP2012506237A (ja) 2012-03-15
JP2012506237A5 true JP2012506237A5 (enExample) 2012-11-22

Family

ID=42062429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011531514A Pending JP2012506237A (ja) 2008-10-21 2009-10-19 Dc−signに対する結合特異性をもつリガンド

Country Status (16)

Country Link
US (1) US20110257373A1 (enExample)
EP (1) EP2356149A2 (enExample)
JP (1) JP2012506237A (enExample)
KR (1) KR20110071139A (enExample)
CN (1) CN102257009A (enExample)
AR (1) AR073905A1 (enExample)
AU (1) AU2009306424A1 (enExample)
BR (1) BRPI0919714A2 (enExample)
CA (1) CA2740856A1 (enExample)
EA (1) EA201100488A1 (enExample)
IL (1) IL212086A0 (enExample)
MX (1) MX2011004244A (enExample)
TW (1) TW201019962A (enExample)
UY (1) UY32189A (enExample)
WO (1) WO2010046337A2 (enExample)
ZA (1) ZA201102763B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011004245A (es) * 2008-10-21 2011-09-06 Domantis Ltd Composicion para dirigirse a las celulas dendriticas.
US9481724B2 (en) * 2011-12-19 2016-11-01 The Rockefeller University hDC-sign binding peptides
WO2023028593A2 (en) * 2021-08-27 2023-03-02 University Of Georgia Research Foundation, Inc. Targeted nanoparticles and their uses related to infectious disease
CN118184795B (zh) * 2022-12-13 2025-03-21 成都维瑾柏鳌生物医药科技有限公司 抗hiv-1的重组蛋白及其应用
CN120591214A (zh) * 2025-07-02 2025-09-05 山东第一医科大学第二附属医院 一种过表达dc-sign基因的重组arh77细胞系及其构建方法与应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0598108A1 (en) * 1992-06-05 1994-05-25 Dade Produktions AG Rabbit single domain antibody and use thereof
NZ540194A (en) * 2002-11-08 2008-07-31 Ablynx Nv Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
JP4889493B2 (ja) * 2003-05-14 2012-03-07 ドマンティス リミテッド ポリペプチドレパートリーから可逆的にアンフォールドするポリペプチドを回収するための方法
JP5087274B2 (ja) * 2003-06-30 2012-12-05 ドマンティス リミテッド ポリペプチド
WO2005018610A1 (en) * 2003-08-21 2005-03-03 Lipotek Pty Ltd In vivo targeting of dendritic cells
US8921528B2 (en) * 2004-06-01 2014-12-30 Domantis Limited Bispecific fusion antibodies with enhanced serum half-life
MX2007006593A (es) * 2004-12-02 2008-03-04 Domantis Ltd Anticuerpos de dominio simple anti-il 1r1 y sus usos terapeuticos.
JP5185624B2 (ja) * 2004-12-02 2013-04-17 ドマンティス リミテッド 血清アルブミンおよびglp−1またはpyyを標的とする二重特異性抗体
JP2008533115A (ja) * 2005-03-18 2008-08-21 ドマンティス リミテッド カンジダ抗原に対する抗体
EP1966242A1 (en) * 2005-12-06 2008-09-10 Domantis Limited Ligands that have binding specificity for egfr and/or vegf and methods of use therefor
US20100021473A1 (en) * 2005-12-06 2010-01-28 Domantis Limited Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use Therefor
BRPI0710572A2 (pt) * 2006-01-24 2013-01-08 Domantis Limited ligante, uso do ligante, mÉtodos para o tratamento de uma doenÇa alÉrgica, de asma e de cÂncer, para a inibiÇço de uma resposta imune do tipo th2, e administraÇço de tratamento anti-il-4 e tratamento anti-il-13, composiÇço farmacÊutica, dispositivo de dispensaÇço de droga, Ácido nucleico isolado ou recombinante, vetor, cÉlula hospedeira, mÉtodos para a produÇço de um ligante e de inibiÇço da proliferaÇço de cÉlulas
WO2008039432A1 (en) * 2006-09-26 2008-04-03 Alexion Pharmaceuticals, Inc. Compositions and methods for enhancing an adjuvant
EP2077863A4 (en) * 2006-10-31 2010-10-06 Domantis Ltd intrabodies
CN101182539A (zh) * 2007-11-06 2008-05-21 浙江大学 Dc-sign启动子荧光素酶报告质粒的构建方法

Similar Documents

Publication Publication Date Title
JP6181145B2 (ja) 改善された特異性を有する新規免疫グロブリン結合タンパク質
JP2013509879A5 (enExample)
JP2015212284A5 (enExample)
JP2007197439A5 (enExample)
JP2005120106A5 (enExample)
JP2016052315A5 (enExample)
JP2013078329A5 (enExample)
JP2012095652A5 (enExample)
JP2016538240A5 (enExample)
JP2015524403A5 (enExample)
JP2009201525A5 (enExample)
WO2011112089A3 (en) Mutated rep encoding sequences for use in aav production
NZ610075A (en) Cxcr2 binding polypeptides
JP2012526530A5 (enExample)
JP2009527226A5 (enExample)
JP2009529509A5 (enExample)
FI3527070T3 (fi) Humanisoituja kevytketjuhiiriä
JP2010227116A5 (enExample)
JP2012525819A5 (enExample)
JP2015527366A5 (enExample)
JP2015537044A5 (enExample)
JP2011521653A5 (enExample)
JP2012507994A5 (enExample)
HRP20221142T1 (hr) Modificirana igg protutijela koja se vežu na transformirajući faktor rasta beta1 s visokim afinitetom, avidnošću i specifičnošću
JP2014534266A5 (enExample)